Copyright Reports & Markets. All rights reserved.

Global Meropenem for Injection Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Meropenem for Injection
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Meropenem for Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 0.25g
    • 1.3.3 0.5g
    • 1.3.4 1g
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Meropenem for Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
    • 1.4.4 Other
  • 1.5 Global Meropenem for Injection Market Size & Forecast
    • 1.5.1 Global Meropenem for Injection Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Meropenem for Injection Sales Quantity (2018-2029)
    • 1.5.3 Global Meropenem for Injection Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Sumitomo Dainippon Pharma Co.,Ltd.
    • 2.1.1 Sumitomo Dainippon Pharma Co.,Ltd. Details
    • 2.1.2 Sumitomo Dainippon Pharma Co.,Ltd. Major Business
    • 2.1.3 Sumitomo Dainippon Pharma Co.,Ltd. Meropenem for Injection Product and Services
    • 2.1.4 Sumitomo Dainippon Pharma Co.,Ltd. Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Sumitomo Dainippon Pharma Co.,Ltd. Recent Developments/Updates
  • 2.2 Joincare Pharmaceutical
    • 2.2.1 Joincare Pharmaceutical Details
    • 2.2.2 Joincare Pharmaceutical Major Business
    • 2.2.3 Joincare Pharmaceutical Meropenem for Injection Product and Services
    • 2.2.4 Joincare Pharmaceutical Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Joincare Pharmaceutical Recent Developments/Updates
  • 2.3 Zhejiang Hisun
    • 2.3.1 Zhejiang Hisun Details
    • 2.3.2 Zhejiang Hisun Major Business
    • 2.3.3 Zhejiang Hisun Meropenem for Injection Product and Services
    • 2.3.4 Zhejiang Hisun Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Zhejiang Hisun Recent Developments/Updates
  • 2.4 CSPC
    • 2.4.1 CSPC Details
    • 2.4.2 CSPC Major Business
    • 2.4.3 CSPC Meropenem for Injection Product and Services
    • 2.4.4 CSPC Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 CSPC Recent Developments/Updates
  • 2.5 Pfizer
    • 2.5.1 Pfizer Details
    • 2.5.2 Pfizer Major Business
    • 2.5.3 Pfizer Meropenem for Injection Product and Services
    • 2.5.4 Pfizer Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Pfizer Recent Developments/Updates
  • 2.6 Haikou Pharmaceutical Factory
    • 2.6.1 Haikou Pharmaceutical Factory Details
    • 2.6.2 Haikou Pharmaceutical Factory Major Business
    • 2.6.3 Haikou Pharmaceutical Factory Meropenem for Injection Product and Services
    • 2.6.4 Haikou Pharmaceutical Factory Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Haikou Pharmaceutical Factory Recent Developments/Updates
  • 2.7 PKU Healthcare
    • 2.7.1 PKU Healthcare Details
    • 2.7.2 PKU Healthcare Major Business
    • 2.7.3 PKU Healthcare Meropenem for Injection Product and Services
    • 2.7.4 PKU Healthcare Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 PKU Healthcare Recent Developments/Updates
  • 2.8 Shanghai Xinya Pharmaceutical
    • 2.8.1 Shanghai Xinya Pharmaceutical Details
    • 2.8.2 Shanghai Xinya Pharmaceutical Major Business
    • 2.8.3 Shanghai Xinya Pharmaceutical Meropenem for Injection Product and Services
    • 2.8.4 Shanghai Xinya Pharmaceutical Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Shanghai Xinya Pharmaceutical Recent Developments/Updates
  • 2.9 Shandong Luoxin Parmaceutical Group
    • 2.9.1 Shandong Luoxin Parmaceutical Group Details
    • 2.9.2 Shandong Luoxin Parmaceutical Group Major Business
    • 2.9.3 Shandong Luoxin Parmaceutical Group Meropenem for Injection Product and Services
    • 2.9.4 Shandong Luoxin Parmaceutical Group Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Shandong Luoxin Parmaceutical Group Recent Developments/Updates
  • 2.10 Shenghuaxi
    • 2.10.1 Shenghuaxi Details
    • 2.10.2 Shenghuaxi Major Business
    • 2.10.3 Shenghuaxi Meropenem for Injection Product and Services
    • 2.10.4 Shenghuaxi Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Shenghuaxi Recent Developments/Updates
  • 2.11 North China Pharmaceutical Group
    • 2.11.1 North China Pharmaceutical Group Details
    • 2.11.2 North China Pharmaceutical Group Major Business
    • 2.11.3 North China Pharmaceutical Group Meropenem for Injection Product and Services
    • 2.11.4 North China Pharmaceutical Group Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 North China Pharmaceutical Group Recent Developments/Updates
  • 2.12 Mylan
    • 2.12.1 Mylan Details
    • 2.12.2 Mylan Major Business
    • 2.12.3 Mylan Meropenem for Injection Product and Services
    • 2.12.4 Mylan Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Mylan Recent Developments/Updates
  • 2.13 Amneal Pharmaceuticals
    • 2.13.1 Amneal Pharmaceuticals Details
    • 2.13.2 Amneal Pharmaceuticals Major Business
    • 2.13.3 Amneal Pharmaceuticals Meropenem for Injection Product and Services
    • 2.13.4 Amneal Pharmaceuticals Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Amneal Pharmaceuticals Recent Developments/Updates
  • 2.14 Auromedics Pharmaceuticals
    • 2.14.1 Auromedics Pharmaceuticals Details
    • 2.14.2 Auromedics Pharmaceuticals Major Business
    • 2.14.3 Auromedics Pharmaceuticals Meropenem for Injection Product and Services
    • 2.14.4 Auromedics Pharmaceuticals Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Auromedics Pharmaceuticals Recent Developments/Updates
  • 2.15 BBraun
    • 2.15.1 BBraun Details
    • 2.15.2 BBraun Major Business
    • 2.15.3 BBraun Meropenem for Injection Product and Services
    • 2.15.4 BBraun Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 BBraun Recent Developments/Updates
  • 2.16 Fresenius Kabi
    • 2.16.1 Fresenius Kabi Details
    • 2.16.2 Fresenius Kabi Major Business
    • 2.16.3 Fresenius Kabi Meropenem for Injection Product and Services
    • 2.16.4 Fresenius Kabi Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Fresenius Kabi Recent Developments/Updates
  • 2.17 Sandoz
    • 2.17.1 Sandoz Details
    • 2.17.2 Sandoz Major Business
    • 2.17.3 Sandoz Meropenem for Injection Product and Services
    • 2.17.4 Sandoz Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Sandoz Recent Developments/Updates
  • 2.18 Bionova Scientific
    • 2.18.1 Bionova Scientific Details
    • 2.18.2 Bionova Scientific Major Business
    • 2.18.3 Bionova Scientific Meropenem for Injection Product and Services
    • 2.18.4 Bionova Scientific Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Bionova Scientific Recent Developments/Updates
  • 2.19 Macleods Pharmaceuticals
    • 2.19.1 Macleods Pharmaceuticals Details
    • 2.19.2 Macleods Pharmaceuticals Major Business
    • 2.19.3 Macleods Pharmaceuticals Meropenem for Injection Product and Services
    • 2.19.4 Macleods Pharmaceuticals Meropenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 Macleods Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Meropenem for Injection by Manufacturer

  • 3.1 Global Meropenem for Injection Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Meropenem for Injection Revenue by Manufacturer (2018-2023)
  • 3.3 Global Meropenem for Injection Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Meropenem for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Meropenem for Injection Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Meropenem for Injection Manufacturer Market Share in 2022
  • 3.5 Meropenem for Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Meropenem for Injection Market: Region Footprint
    • 3.5.2 Meropenem for Injection Market: Company Product Type Footprint
    • 3.5.3 Meropenem for Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Meropenem for Injection Market Size by Region
    • 4.1.1 Global Meropenem for Injection Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Meropenem for Injection Consumption Value by Region (2018-2029)
    • 4.1.3 Global Meropenem for Injection Average Price by Region (2018-2029)
  • 4.2 North America Meropenem for Injection Consumption Value (2018-2029)
  • 4.3 Europe Meropenem for Injection Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Meropenem for Injection Consumption Value (2018-2029)
  • 4.5 South America Meropenem for Injection Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Meropenem for Injection Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Meropenem for Injection Sales Quantity by Type (2018-2029)
  • 5.2 Global Meropenem for Injection Consumption Value by Type (2018-2029)
  • 5.3 Global Meropenem for Injection Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Meropenem for Injection Sales Quantity by Application (2018-2029)
  • 6.2 Global Meropenem for Injection Consumption Value by Application (2018-2029)
  • 6.3 Global Meropenem for Injection Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Meropenem for Injection Sales Quantity by Type (2018-2029)
  • 7.2 North America Meropenem for Injection Sales Quantity by Application (2018-2029)
  • 7.3 North America Meropenem for Injection Market Size by Country
    • 7.3.1 North America Meropenem for Injection Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Meropenem for Injection Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Meropenem for Injection Sales Quantity by Type (2018-2029)
  • 8.2 Europe Meropenem for Injection Sales Quantity by Application (2018-2029)
  • 8.3 Europe Meropenem for Injection Market Size by Country
    • 8.3.1 Europe Meropenem for Injection Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Meropenem for Injection Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Meropenem for Injection Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Meropenem for Injection Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Meropenem for Injection Market Size by Region
    • 9.3.1 Asia-Pacific Meropenem for Injection Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Meropenem for Injection Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Meropenem for Injection Sales Quantity by Type (2018-2029)
  • 10.2 South America Meropenem for Injection Sales Quantity by Application (2018-2029)
  • 10.3 South America Meropenem for Injection Market Size by Country
    • 10.3.1 South America Meropenem for Injection Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Meropenem for Injection Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Meropenem for Injection Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Meropenem for Injection Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Meropenem for Injection Market Size by Country
    • 11.3.1 Middle East & Africa Meropenem for Injection Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Meropenem for Injection Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Meropenem for Injection Market Drivers
  • 12.2 Meropenem for Injection Market Restraints
  • 12.3 Meropenem for Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Meropenem for Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Meropenem for Injection
  • 13.3 Meropenem for Injection Production Process
  • 13.4 Meropenem for Injection Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Meropenem for Injection Typical Distributors
  • 14.3 Meropenem for Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Meropenem for Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    This report is a detailed and comprehensive analysis for global Meropenem for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Meropenem for Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Meropenem for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Meropenem for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Meropenem for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Meropenem for Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Meropenem for Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sumitomo Dainippon Pharma Co.,Ltd., Joincare Pharmaceutical, Zhejiang Hisun, CSPC and Pfizer, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Meropenem for Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    0.25g
    0.5g
    1g
    Market segment by Application
    Hospitals
    Clinics
    Other
    Major players covered
    Sumitomo Dainippon Pharma Co.,Ltd.
    Joincare Pharmaceutical
    Zhejiang Hisun
    CSPC
    Pfizer
    Haikou Pharmaceutical Factory
    PKU Healthcare
    Shanghai Xinya Pharmaceutical
    Shandong Luoxin Parmaceutical Group
    Shenghuaxi
    North China Pharmaceutical Group
    Mylan
    Amneal Pharmaceuticals
    Auromedics Pharmaceuticals
    BBraun
    Fresenius Kabi
    Sandoz
    Bionova Scientific
    Macleods Pharmaceuticals
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Meropenem for Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Meropenem for Injection, with price, sales, revenue and global market share of Meropenem for Injection from 2018 to 2023.
    Chapter 3, the Meropenem for Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Meropenem for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Meropenem for Injection market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Meropenem for Injection.
    Chapter 14 and 15, to describe Meropenem for Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now